Clinical Trial Update: Efficacy and Safety of Flutiform K-haler in Patients With Uncontrolled Asthma Following Mid-dose ICS/LABA DPI Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial update on efficacy and safety of Flutiform K-haler in uncontrolled asthma patients after mid-dose ICS/LABA therapy; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Flutiform K-haler

Snippet

Sponsor: Mundipharma Korea Ltd | Conditions: Asthma | Phase 3 | Status: TERMINATED